September 17, 2010 - Pennsylvania - Women like Elizabeth Coleman who underwent hormone replacement therapy (HRT) are among many of the victims claiming the HRT drugs caused her breast cancer.
A lower Pennsylvania court ruled that she should have known about the risk and supported the drug manufacturer Pfizer's claim that her 2-year statute of limitations had expired.
PharmaLive.com reports that Coleman's case, along with 13 other similar cases, have gone back under review after the Superior Court of Pennsylvania found that the lawsuits were unfairly dismissed. The cases involved 14 women who underwent HRT treatments and were diagnosed with breast cancer between 1998 and 2002. The HRT drugs Prempro and Premarin were marketed by Pfizer's Wyeth unit and the Pharmacia unit marketed Provera.
The higher Pennsylvania court found that the women should not have been expected to make the link between the HRT treatments and their breast cancer, completely reversing the opinion of the lower court. Arguments for their cases stated that there was no reasoning to suggest that the diagnosis of breast cancer would point to the causation by a 3rd party.
With the reinstatement of these cases, as many as 1,000 mass tort lawsuits could be eligible to return to the court docket in the Philadelphia Common Pleas Court.
Hiring a Philadelphia Product Liability Attorney
If you or a loved one suffered injuries related to a product defect, you may be able to file a product liability claim for any injuries you sustained. If you need a Philadelphia product liability attorney to assist with reviewing your case, contact us at the Law Offices of White & Williams to speak with an experienced attorney who can help protect your rights - 877-944-8356